219 related articles for article (PubMed ID: 29242087)
1. Complications with use of misoprostol for abortion in Madagascar: between ease of access and lack of information.
Pourette D; Mattern C; Ratovoson R; Raharimalala P
Contraception; 2018 Feb; 97(2):116-121. PubMed ID: 29242087
[TBL] [Abstract][Full Text] [Related]
2. "It is just like having a period with back pain": exploring women's experiences with community-based distribution of misoprostol for early abortion on the Thailand-Burma border.
Tousaw E; Moo SNHG; Arnott G; Foster AM
Contraception; 2018 Feb; 97(2):122-129. PubMed ID: 28780239
[TBL] [Abstract][Full Text] [Related]
3. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
Ortiz J; Blades N; Prada E
Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
[TBL] [Abstract][Full Text] [Related]
5. Women's experiences with the use of medical abortion in a legally restricted context: the case of Argentina.
Ramos S; Romero M; Aizenberg L
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):4-15. PubMed ID: 25702064
[TBL] [Abstract][Full Text] [Related]
6. Opening a door to safe abortion: international perspectives on medical abortifacient use.
Pollack AE; Pine RN
J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):186-8. PubMed ID: 10846335
[TBL] [Abstract][Full Text] [Related]
7. Unsafe abortion requiring hospital admission in the Eastern Highlands of Papua New Guinea--a descriptive study of women's and health care workers' experiences.
Vallely LM; Homiehombo P; Kelly-Hanku A; Whittaker A
Reprod Health; 2015 Mar; 12():22. PubMed ID: 25889957
[TBL] [Abstract][Full Text] [Related]
8. Evaluating women's acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study.
Atuhairwe S; Hanson C; Atuyambe L; Byamugisha J; Tumwesigye NM; Ssenyonga R; Gemzell-Danielsson K
BMC Womens Health; 2022 Nov; 22(1):434. PubMed ID: 36335344
[TBL] [Abstract][Full Text] [Related]
9. Pathways to seeking medication abortion care: A qualitative research in Uttar Pradesh, India.
Srivastava A; Saxena M; Percher J; Diamond-Smith N
PLoS One; 2019; 14(5):e0216738. PubMed ID: 31083665
[TBL] [Abstract][Full Text] [Related]
10. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
Petitet PH; Ith L; Cockroft M; Delvaux T
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
[TBL] [Abstract][Full Text] [Related]
11. Women's abortion seeking behavior under restrictive abortion laws in Mexico.
Juarez F; Bankole A; Palma JL
PLoS One; 2019; 14(12):e0226522. PubMed ID: 31881041
[TBL] [Abstract][Full Text] [Related]
12. Abortion in two francophone African countries: a study of whether women have begun to use misoprostol in Benin and Burkina Faso.
Baxerres C; Boko I; Konkobo A; Ouattara F; Guillaume A
Contraception; 2018 Feb; 97(2):130-136. PubMed ID: 29104024
[TBL] [Abstract][Full Text] [Related]
13. Voluntary Contraceptive Uptake Among Postabortion Care Clients Treated With Misoprostol in Rwanda.
Packer C; Pack AP; McCarraher DR
Glob Health Sci Pract; 2019 Aug; 7(Suppl 2):S247-S257. PubMed ID: 31455622
[TBL] [Abstract][Full Text] [Related]
14. Introducing misoprostol for the treatment of incomplete abortion in Nigeria.
Dah T; Akiode A; Awah P; Fetters T; Okoh M; Ujah I; Oji E
Afr J Reprod Health; 2011 Dec; 15(4):42-50. PubMed ID: 22571104
[TBL] [Abstract][Full Text] [Related]
15. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries.
Shochet T; Diop A; Gaye A; Nayama M; Sall AB; Bukola F; Blandine T; Abiola OM; Dao B; Olayinka O; Winikoff B
BMC Pregnancy Childbirth; 2012 Nov; 12():127. PubMed ID: 23150927
[TBL] [Abstract][Full Text] [Related]
16. Women's perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study.
Chakhame BM; Darj E; Mwapasa M; Kafulafula UK; Maluwa A; Odland JØ; Odland ML
Reprod Health; 2023 Feb; 20(1):26. PubMed ID: 36732793
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
[TBL] [Abstract][Full Text] [Related]
18. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
19. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study.
Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD
BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
